Activated bifidobacteria and methods of use thereof
US10716816B2 · kind B2 · utility
1Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2015 |
| Grant date | Jul 21, 2020 |
| Priority date | — |
| Expiry date | Oct 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2400/529
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Some embodiments of the invention include a composition and method for treating dysbiosis in infants. The composition may include a mixture of activated bifidobacteria and a complex oligosaccharide wherein the complex oligosaccharide may be derived from a human or non-human source.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.